Annual Working Capital
-$42.81 M
-$797.91 M-105.67%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual working capital is -$42.81 million, with the most recent change of -$797.91 million (-105.67%) on December 31, 2023.
- During the last 3 years, IRWD annual working capital has fallen by -$506.48 million (-109.23%).
- IRWD annual working capital is now -105.67% below its all-time high of $755.10 million, reached on December 31, 2022.
Performance
IRWD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$129.22 M
-$3.45 M-2.60%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly working capital is $129.22 million, with the most recent change of -$3.45 million (-2.60%) on September 30, 2024.
- Over the past year, IRWD quarterly working capital has stayed the same.
- IRWD quarterly working capital is now -84.66% below its all-time high of $842.53 million, reached on March 31, 2023.
Performance
IRWD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IRWD Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -105.7% | 0.0% |
| 3 y3 years | -109.2% | -77.9% |
| 5 y5 years | -129.1% | -77.9% |
IRWD Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -105.7% | at low | -84.7% | +391.9% |
| 5 y | 5-year | -105.7% | at low | -84.7% | +391.9% |
| alltime | all time | -105.7% | at low | -84.7% | +391.9% |
Ironwood Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $129.22 M(-2.6%) |
| Jun 2024 | - | $132.67 M(-399.7%) |
| Mar 2024 | - | -$44.27 M(+3.4%) |
| Dec 2023 | -$42.81 M(-105.7%) | -$42.81 M(+58.7%) |
| Sep 2023 | - | -$26.97 M(-320.9%) |
| Jun 2023 | - | $12.21 M(-98.6%) |
| Mar 2023 | - | $842.53 M(+11.6%) |
| Dec 2022 | $755.10 M(+29.4%) | $755.10 M(+12.4%) |
| Sep 2022 | - | $671.88 M(+13.0%) |
| Jun 2022 | - | $594.53 M(+5.7%) |
| Mar 2022 | - | $562.70 M(-3.6%) |
| Dec 2021 | $583.53 M(+25.9%) | $583.53 M(+6.2%) |
| Sep 2021 | - | $549.68 M(+13.1%) |
| Jun 2021 | - | $485.90 M(-5.6%) |
| Mar 2021 | - | $514.64 M(+11.0%) |
| Dec 2020 | $463.67 M(+74.4%) | $463.67 M(+15.8%) |
| Sep 2020 | - | $400.42 M(+15.2%) |
| Jun 2020 | - | $347.58 M(+13.5%) |
| Mar 2020 | - | $306.35 M(+15.2%) |
| Dec 2019 | $265.92 M(+81.0%) | $265.92 M(+29.8%) |
| Sep 2019 | - | $204.84 M(+86.0%) |
| Jun 2019 | - | $110.12 M(+32.3%) |
| Mar 2019 | - | $83.26 M(-43.3%) |
| Dec 2018 | $146.91 M(-40.2%) | $146.91 M(+8.0%) |
| Sep 2018 | - | $135.97 M(-26.3%) |
| Jun 2018 | - | $184.56 M(-13.5%) |
| Mar 2018 | - | $213.39 M(-13.1%) |
| Dec 2017 | $245.57 M(-15.0%) | $245.57 M(-1.6%) |
| Sep 2017 | - | $249.56 M(-4.6%) |
| Jun 2017 | - | $261.51 M(-6.3%) |
| Mar 2017 | - | $278.96 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $289.05 M(-31.8%) | $289.05 M(+0.5%) |
| Sep 2016 | - | $287.50 M(-2.6%) |
| Jun 2016 | - | $295.14 M(-29.3%) |
| Mar 2016 | - | $417.59 M(-1.5%) |
| Dec 2015 | $423.74 M(+86.0%) | $423.74 M(-3.3%) |
| Sep 2015 | - | $438.00 M(-5.8%) |
| Jun 2015 | - | $464.86 M(+127.8%) |
| Mar 2015 | - | $204.06 M(-10.4%) |
| Dec 2014 | $227.77 M(+21.1%) | $227.77 M(-8.9%) |
| Sep 2014 | - | $250.02 M(-12.0%) |
| Jun 2014 | - | $284.13 M(-14.6%) |
| Mar 2014 | - | $332.81 M(+76.9%) |
| Dec 2013 | $188.09 M(+45.2%) | $188.09 M(-20.3%) |
| Sep 2013 | - | $236.13 M(-19.1%) |
| Jun 2013 | - | $291.81 M(+37.0%) |
| Mar 2013 | - | $212.95 M(+64.4%) |
| Dec 2012 | $129.50 M(+26.4%) | $129.50 M(-22.3%) |
| Sep 2012 | - | $166.77 M(+42.6%) |
| Jun 2012 | - | $116.96 M(-24.0%) |
| Mar 2012 | - | $153.98 M(+50.3%) |
| Dec 2011 | $102.43 M(-47.4%) | $102.43 M(-5.1%) |
| Sep 2011 | - | $107.92 M(-21.5%) |
| Jun 2011 | - | $137.54 M(-18.4%) |
| Mar 2011 | - | $168.52 M(-13.4%) |
| Dec 2010 | $194.65 M(+159.5%) | $194.65 M(-13.5%) |
| Jun 2010 | - | $224.96 M(-10.5%) |
| Mar 2010 | - | $251.41 M(+235.2%) |
| Dec 2009 | $75.01 M(+8.8%) | $75.01 M(-1.1%) |
| Sep 2009 | - | $75.86 M(+10.0%) |
| Dec 2008 | $68.93 M(-22.8%) | $68.93 M |
| Dec 2007 | $89.24 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual working capital year-on-year change?
- What is Ironwood Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly working capital year-on-year change?
What is Ironwood Pharmaceuticals annual working capital?
The current annual working capital of IRWD is -$42.81 M
What is the all time high annual working capital for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual working capital is $755.10 M
What is Ironwood Pharmaceuticals annual working capital year-on-year change?
Over the past year, IRWD annual working capital has changed by -$797.91 M (-105.67%)
What is Ironwood Pharmaceuticals quarterly working capital?
The current quarterly working capital of IRWD is $129.22 M
What is the all time high quarterly working capital for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly working capital is $842.53 M
What is Ironwood Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, IRWD quarterly working capital has changed by $0.00 (0.00%)